Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007412,
umls-concept:C0021469,
umls-concept:C0030685,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0037791,
umls-concept:C0129935,
umls-concept:C0391871,
umls-concept:C0441472,
umls-concept:C0521428,
umls-concept:C0680255,
umls-concept:C0729217,
umls-concept:C1283071,
umls-concept:C1963578,
umls-concept:C2603343
|
pubmed:issue |
11
|
pubmed:dateCreated |
1989-4-18
|
pubmed:abstractText |
1. The ability of P-286 (N,N-diisopropyl-N'-isoamyl-N'-diethylaminoethylurea) to reduce selectively the release of catecholamines from the adrenal medulla has been studied in urethane-anaesthetized rats. 2. Pressor responses to acetylcholine (Ach) and the nicotinic receptor-agonist 1,4-dimethylphenylpiperazine (DMPP) in rats treated with atropine, (+/-)-propranolol and guanethidine were used as the index of adrenal catecholamine release. 3. The injection of P-286 (1-10 mg/kg, i.v.) elicited a dose-dependent bradycardia which was associated with hypotension. P-286 reduced pressor responses to Ach and DMPP in a dose-dependent manner with an IC50 of 2.5 mg/kg and, following near complete blockade, pressor responses to DMPP returned to 50% of control after 90 min. 4. In non-atropinized rats, P-286 (30 mg/kg, i.v.) was without effect on the bradycardic responses elicited by stimulation of the right vagus nerve at frequencies of 5-40 Hz while pressor responses to DMPP in bilaterally adrenalectomized, non-guanethidine treated rats were reduced by approximately 50% after P-286 (10 mg/kg, i.v.). 5. The latter effect of P-286 on responses to DMPP in adrenalectomized rats cannot be attributed to ganglionic blockade since in rats with intact adrenals P-286 (10 mg/kg, i.v.) also reduced pressor responses to i.v. adrenaline and i.v. angiotensin II by approximately 50%. Thus the reduction in response to DMPP in adrenalectomized rats and to the non-nicotinic agonists may be a reflection of an action on the mechanism of contraction of vascular smooth muscle; that is, at a post-receptor event. 6. The results of the study show that P-286 selectively reduces adrenal catecholamine release at doses which do not affect autonomic ganglia. Its usefulness as a tool in cardiovascular research, however, may be limited by an action of vascular smooth muscle.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Dimethylphenylpiperazinium Iodide,
http://linkedlifedata.com/resource/pubmed/chemical/Epinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/N,N-diisopropyl-N'-isoamyl-N'-diethy...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Muscarinic,
http://linkedlifedata.com/resource/pubmed/chemical/Urea
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0305-1870
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
815-25
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3229006-Acetylcholine,
pubmed-meshheading:3229006-Adrenal Medulla,
pubmed-meshheading:3229006-Angiotensin II,
pubmed-meshheading:3229006-Animals,
pubmed-meshheading:3229006-Blood Pressure,
pubmed-meshheading:3229006-Catecholamines,
pubmed-meshheading:3229006-Dimethylphenylpiperazinium Iodide,
pubmed-meshheading:3229006-Epinephrine,
pubmed-meshheading:3229006-Ganglia, Autonomic,
pubmed-meshheading:3229006-Heart Rate,
pubmed-meshheading:3229006-Male,
pubmed-meshheading:3229006-Rats,
pubmed-meshheading:3229006-Rats, Inbred Strains,
pubmed-meshheading:3229006-Receptors, Muscarinic,
pubmed-meshheading:3229006-Urea
|
pubmed:year |
1988
|
pubmed:articleTitle |
Studies on the specificity of the inhibitory action of N,N-diisopropyl-N'-isoamyl-N'-diethylaminoethylurea (P-286) on adrenal catecholamine release in the anaesthetized rat.
|
pubmed:affiliation |
School of Pharmacology, Victorian College of Pharmacy, Parkville, Victoria, Australia.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|